Mesoblast gets EMA nod to start Revascor Phase 2 trial
The Phase 2 trial – Allogeneic Mesenchymal precursor cell Infusion in myoCardial Infarction (AMICI) – is expected to initially enroll patients at multiple European sites, including in the
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
Premier Source provides consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic and biotechnology manufacturers, as well as other health services companies. AmerisourceBergen Business Development senior vice